# Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.

> **NCT06136377** · NA · NOT_YET_RECRUITING · sponsor: **Centre Georges Francois Leclerc** · enrollment: 35 (estimated)

## Conditions studied

- Patients With Metastatic Castration-resistant Prostate Cancer

## Interventions

- **RADIATION:** 177Lu-PSMA-617 PET scan

## Key facts

- **NCT ID:** NCT06136377
- **Lead sponsor:** Centre Georges Francois Leclerc
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01-31
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06136377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06136377, "Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06136377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*